<?xml version="1.0" encoding="UTF-8"?>
<ref id="B90">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Omotuyi</surname>
    <given-names>I. O.</given-names>
   </name>
   <name>
    <surname>Nash</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Ajiboye</surname>
    <given-names>B. O.</given-names>
   </name>
   <name>
    <surname>Olumekun</surname>
    <given-names>V. O.</given-names>
   </name>
   <name>
    <surname>Oyinloye</surname>
    <given-names>B. E.</given-names>
   </name>
   <name>
    <surname>Osuntokun</surname>
    <given-names>O. T.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Aframomum melegueta K.Schum. secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: 
   <italic>in vitro</italic> validation of furin inhibition
  </article-title>.
  <source>Phytotherapy research : ptr</source>
  <pub-id pub-id-type="doi">10.1002/ptr.6843</pub-id>
 </mixed-citation>
</ref>
